Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
Susumu S. Kobayashi and Daniel B. Costa and Koichi Goto and Kazutaka Miyadera and Hiroyuki Yasuda and Kaoru Funabashi and Akihiro Hashimoto and Ryoto Fujita and Miki Terasaka and Tomonori Haruma and Toshiharu Komori and Naomi Abe and Mikiko Shibuya and Yumi Hakozaki and Rumi Fujioka and Akihiro Ohashi and Shinichi Hasako and Hibiki Udagawa,Tables S1-3 and Figures S1-4 from TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant <i>EGFR</i> Mutations,,,American Association for Cancer Research (AACR),2023-04-03,,,,https://cir.nii.ac.jp/crid/1870020692956229248,https://doi.org/10.1158/1541-7786.22515805